Co-Diagnostics, Inc. (CODX) › Operating Cash FlowCo-Diagnostics, Inc. (CODX) — Operating Cash FlowAnnual figures by period end, from SEC filings.2016-12-31: -$1.31M2017-12-31: -$3.21M2018-12-31: -$4.08M2019-12-31: -$5.53M2020-12-31: $28.17M2021-12-31: $41.08M2022-12-31: $6.57M2023-12-31: -$22.08M2024-12-31: -$29.16M2025-12-31: -$29.14M-$29.14M2016-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$29.14M—2026-03-31From 2025-01-012024-12-31-$29.16M—2026-03-31From 2024-01-012023-12-31-$22.08M-436.2%2025-03-27From 2023-01-012022-12-31$6.57M-84.0%2024-03-14From 2022-01-012021-12-31$41.08M+45.9%2023-03-16From 2021-01-012020-12-31$28.17M—2022-03-24From 2020-01-012019-12-31-$5.53M—2021-03-25From 2019-01-012018-12-31-$4.08M—2020-03-30From 2018-01-012017-12-31-$3.21M—2019-04-01From 2017-01-012016-12-31-$1.31M—2018-03-28From 2016-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)